The new Center for Brain Health at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, is studying midlife testing for early-onset dementia with blood-based biomarkers, and exploring emerging genetic treatments for early-onset and other dementias.

Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The funding will support a clinical study evaluating motor and cognitive factors associated with changes in walking for people with Parkinson’s disease who use MedRhythms’ MOVIVE (MR-005), a safe, use-at-home medical device that delivers rhythmic auditory stimulation (RAS) to support gait rehabilitation and motor function.

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the misfolding of a specific protein, leading to its toxic accumulation in the form of filamentous deposits in various organs. Researchers at the University of Geneva (UNIGE), in collaboration with the Università della Svizzera Italiana (USI), have succeeded for the first time in determining the three-dimensional structure of abnormal protein deposits from a skin biopsy of a living patient. This breakthrough opens the door to earlier, less invasive diagnosis, potentially accessible to a much larger number of patients and applicable to other diseases. The study is published in Nature Communications.